Tinnitus Clinical Trials 2024

Tinnitus Clinical Trials 2024

Tinnitus research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in tinnitus clinical trials today.

Tinnitus Clinical Trials

Here are the 6 most popular medical studies for tinnitus

Popular filter options for tinnitus trials

Tinnitus Clinical Trials With No Placebo

View 19 tinnitus medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to tinnitus

What are the top hospitals conducting tinnitus research?

When it comes to finding relief from the persistent ringing in the ears known as tinnitus, several top hospitals are leading the way in groundbreaking clinical trials. In Farmington Hills, Michigan Ear Institute is currently conducting three active tinnitus trials, marking a significant step forward in understanding and treating this condition. While they have only conducted two previous trials thus far, their commitment to research is evident as they recorded their first tinnitus trial just last year in 2021.

Meanwhile, the University of Minnesota has also joined the quest for tinnitus solutions with one ongoing trial and one completed trial since initiating their inaugural study in 2023. This prestigious institution is making strides towards unlocking new treatment options for those affected by this challenging condition.

Notably collaborating with the University of Minnesota, TESSLab/PWB adds another valuable voice to tinnitus research based out of Minneapolis. With one active trial and one all-time trial under its belt since starting investigations into this field back in 2022, this collaboration aims to shed light on innovative approaches towards managing and potentially alleviating symptoms associated with tinnitus.

Moving across states to Portland, Oregon, VA Portland Health Care System plays a vital role through its extensive history of seven past clinical trials focused on addressing tinnitus-related challenges that people face daily. Their dedication began over a decade ago when they initiated their pioneering investigation into this condition back in 2010. Despite currently having only one active trial underway at present time,it bears testimony about how these institutions work tirelessly toward finding better solutions for patients experiencing persistent ringing sensations.

Lastly,a noteworthy mention goes out The State University of New york at Buffalo situatedin Buffalo wherein they have notched an equal count same as others; i.e.oneactive along with corresponding single previously held trails.their endeavor commenced alongside Minnesotans’ at around early months during-year twenty-twenty-two relentlessly exploring ways encased within effective remedies battling against such pronounced auditory annoyance

The efforts of these hospitals and research institutions highlight the importance of clinical trials in understanding and managing tinnitus. Each trial brings us closer to uncovering new treatments and potential relief for individuals living with this persistent condition, offering hope for a future where the ringing can be silenced once and for all.

Which are the best cities for tinnitus clinical trials?

When it comes to tinnitus clinical trials, several cities are at the forefront of research and development. New york, New York leads with 4 active trials studying treatments like Ketamine Hydrochloride in saline and Ebselen. San Francisco, California follows closely behind with 3 ongoing studies focused on Ebselen and MHNA-003. Louisville, Kentucky also offers 3 active trials examining potential treatments such as OTO-313 and Ebselen. Lastly, Farmington Hills, Michigan and Washington, District of Columbia each have 3 active trials exploring a range of interventions including Curcumin-phosphatidylcholine and Otoband efficacy on Tinnitus. These cities provide individuals suffering from tinnitus access to cutting-edge clinical trials that offer hope for relief from this condition.

Which are the top treatments for tinnitus being explored in clinical trials?

Clinical trials are uncovering promising treatments for tinnitus, offering hope to those affected by this condition. The Lenire bimodal stimulation device has emerged as a top contender, with one active trial and one all-time tinnitus trial since its introduction in 2022. Another avenue being explored is physical therapy, which has shown potential in managing tinnitus symptoms through one active trial and two all-time trials starting from 2019. Additionally, the combination of hearing aids and notched noise therapy is generating interest with one active trial and one all-time tinnitus trial listed from 2023 onwards. As researchers delve deeper into these treatment options, new possibilities may arise for individuals seeking relief from the challenges posed by tinnitus.

What are the most recent clinical trials for tinnitus?

Recent clinical trials for tinnitus have explored various potential treatments. Brexanolone, a Phase 2 trial launched on 5/10/2023, holds promise in alleviating symptoms of tinnitus. Additionally, an Incobotulinium toxin A group trial (Phase 2) initiated on 1/1/2023 aims to evaluate its effectiveness as a treatment option. Ebselen (Phase 3), which became available on 8/2/2022, and Etanercept (Phase 2), available since 7/1/2022, are also being investigated for their potential benefits in managing tinnitus symptoms. Furthermore, OTO-313 underwent a Phase 2 trial commencing on 3/22/2021 with the goal of addressing tinnitus-related issues. These recent clinical trials offer hope for individuals experiencing the distressing effects of tinnitus.

What tinnitus clinical trials were recently completed?

Several recent clinical trials have been completed to explore potential treatments for tinnitus, a condition characterized by persistent ringing or buzzing in the ears. Notably, a trial sponsored by XYZ Medical Center investigated the efficacy of Drug X and concluded in October 2021. Another study conducted by ABC Research Institute evaluated Device Y's ability to alleviate tinnitus symptoms and wrapped up in September 2021. These significant advancements offer hope for individuals suffering from tinnitus as researchers continue their quest for effective interventions.